中文版 | English

在结果中检索

HFCAS OpenIR

浏览/检索结果: 共3条，第1-3条 帮助

限定条件            
已选(0)清除 条数/页：   排序方式：
Genetically Predicted Circulating Level of C-Reactive Protein Is Not Associated With Prostate Cancer Risk 期刊论文
FRONTIERS IN ONCOLOGY, 2020, 卷号: 10
作者:  He, Chiyu;  Qian, Yu;  Liu, Bin;  Yang, Shaoxue;  Ye, Ding;  Sun, Xiaohui;  Chen, Tianhui;  Mao, Yingying
收藏  |  浏览/下载：62/0  |  提交时间：2020/12/28
C-reactive protein  genome-wide association study  Mendelian randomization  prostate cancer  single-nucleotide polymorphisms  
Risk of Second Primary Malignancies in Colon Cancer Patients Treated With Colectomy 期刊论文
FRONTIERS IN ONCOLOGY, 2020, 卷号: 10
作者:  Zhang, Bo;  Guo, Kaibo;  Zheng, Xueer;  Sun, Leitao;  Shen, Minhe;  Ruan, Shanming
收藏  |  浏览/下载：39/0  |  提交时间：2020/10/26
second primary malignancy  colon cancer  prostate cancer  competing risk model  nomogram  
Tumor Mutation Burden Correlates With Efficacy of Chemotherapy/Targeted Therapy in Advanced Non-Small Cell Lung Cancer 期刊论文
FRONTIERS IN ONCOLOGY, 2020, 卷号: 10
作者:  Lin, Chen;  Shi, Xun;  Zhao, Jun;  He, Qiong;  Fan, Yun;  Xu, Weizhen;  Shao, Yang;  Yu, Xinmin;  Jin, Ying
收藏  |  浏览/下载：44/0  |  提交时间：2020/10/26
tumor mutation burden (TMB)  clinical benefit  epidermal growth factor receptor tyrosine kinase inhibitors (EGFR-TKIs)  chemotherapy  non-small cell lung cancer (NSCLC)